Ferring Pharmaceuticals is committed to obstetrics and gynaecology where its products concentrate on utilising the body’s natural processes to help couples conceive and to ensure a successful pregnancy.
By being able to offer new and innovative products in these areas, it is Ferring’s vision to provide the best treatments to aid every stage of the reproductive cycle.
Gynaecology and infertility
Gynaecology deals with disorders of the female reproductive system, and includes the treatment of infertility. Infertility is one of Ferring’s key areas of interest and we are firmly committed to progress in the field of Assisted Reproductive Technology (ART).
With many women postponing childbirth until later in life, age-related infertility has become an increasing problem. In fact, infertility affects 60 to 80 million couples worldwide, up to a quarter of all couples, and can bring devastating personal consequences.
Mounting infertility has created a growing demand for in-vitro fertilisation. Ferring has been conducting research into infertility for many years and its products have an excellent track record for over a decade.
Ferring’s research division continues to explore new and exciting routes aimed to meet the body on its own terms to help conquer infertility problems.
Obstetrics
Obstetrics focuses on the care of women during pregnancy, leading to a successful labour and birth. But sometimes the start of labour can begin too early, or even too late.
Most pregnancies proceed to full term without any complications, but where additional help is needed, Ferring’s obstetrics portfolio is renowned for offering effective options and products with a well established safety and efficacy profile for the mother and baby.
Ferring is considered one of the leaders in obstetric care and continues to investigate new therapies to reduce the number of infants that are born prematurely. Current projects include the development of a new oxytocin antagonist designed for acute and maintenance tocolysis (to stop and prevent further contractions of the uterus).
The message has been sent
Your friend has been sent the following email: